Skip to content

Culturally Engaged REcovery: MOms Connected Through Native communitY

Culturally Engaged REcovery - MOms Connected Through Native communitY (CEREMONY)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06747442
Acronym
CEREMONY
Enrollment
270
Registered
2024-12-24
Start date
2026-05-26
Completion date
2029-03-01
Last updated
2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cultural Adaptation, Maternal Morbidity and Mortality, Pregnancy, Substance Use Disorders (SUD)

Keywords

Pregnancy, Prenatal care, Substance Use Disorder, Native and Indigenous Health, Culturally adapted care

Brief summary

Pregnant and postpartum American Indian and Alaska Native people (Native mothers) face a more than two-fold higher risk of maternal mortality compared to non-Hispanic White mothers. Deaths related to substance use (SU) and mental health conditions are a leading cause of preventable maternal mortality, including among Native mothers, making these conditions a strong target for reducing maternal mortality and morbidity. The objective of this study is to 1) adapt evidence-based perinatal care models that integrate pregnancy and postpartum care with SU treatment and care to meet the needs of Native mothers, and 2) assess the implementation and efficacy of that model for participants with substance use disorder who identify as Native receiving prenatal care at Sacred Circle Healthcare in Salt Lake City, Utah.

Detailed description

Pregnant and postpartum American Indian and Alaska Native people (Native mothers) face a more than two-fold higher risk of maternal mortality compared to non-Hispanic White mothers. Deaths related to substance use (SU) and mental health conditions reflect a leading cause of preventable maternal mortality, including among Native mothers, making these conditions a strong target for reducing maternal mortality and morbidity. The Utah Maternal Mortality Review Committee (MMRC) has identified access to substance use disorder (SUD) treatment including medication for opioid use disorder (MOUD), mental health care, improved social support, decreased stigma against SUD, and care coordination, particularly in the postpartum period (when the majority of deaths occur) as actionable intervention points. The objective of this study, Culturally-Engaged REcovery - MOms connected through Native CommunitY (CEREMONY), is to adapt evidence-based perinatal care models that integrate pregnancy and postpartum care with SU/SUD treatment and care to meet the needs of Native mothers. With a partnership at Sacred Circle Clinic, a federal Tribal Contract clinic operated by the Confederated Tribes of the Goshute Reservation, the investigators are uniquely poised to respond to the expressed needs of Native mothers and stakeholders, who identified a lack of culturally-integrated SUD care as a significant gap in perinatal care for Native mothers. The investigators will do this by building upon the strong, evidence-based foundation of the University of Utah integrated perinatal SUD clinic called Substance Use and Pregnancy - Recovery, Addiction, and Dependence (SUPeRAD). The SUPeRAD model directly addresses the actionable intervention points identified by the MMRC to prevent SUD-related maternal deaths, but is not specifically adapted to Native mothers' needs. The rationale for this study is that there is a critical knowledge gap in the adaptation and implementation of integrated perinatal SUD care specifically for Native mothers. The CEREMONY study will fill this gap by adapting the SUPeRAD clinic model to the needs of Native mothers using the validated ADAPT-ITT adaptation framework, informed by human centered design and community-based participatory research (Aim 1; not part of the observation trial submission described on this website); and then studying the adapted, culturally-integrated perinatal SUD care intervention at Sacred Circle Healthcare using a Hybrid Type 1 effectiveness-implementation study (Aim 2a&b). The Hybrid Type 1 design will provide important, reliable data on the clinical effectiveness of culturally adapted perinatal SUD care for Native mothers (Aim 2a) while also producing novel data on the implementation process (Aim 2b). Successful completion of these Aims will provide implementation and training protocols that can be used to guide adaptation and implementation of culturally-adapted perinatal SUD care in other settings across the US. Sacred Circle Healthcare will be implementing the new care model and offering it to all patients who identify as Native and having a substance use disorder. Within that group, the CEREMONY study will invite patients who meet study inclusion criteria to participate in the observational research study. Participants enrolled prospectively will be compared to a historical cohort, with data pulled from the Utah Population Database, for our primary outcome. The historical cohort will be comprised on deidentified data from individuals over 18 years old with delivery of an infant greater than 20 weeks' gestation between 2020 and the most recent year of available data (approximately 2027-28) who had at least one visit with a Utah health provider before delivery and identify as American Indian/Alaska Native based on vital records or hospital records.

Interventions

BEHAVIORALCradleboard Journey

Cradleboard Journey is an integrated perinatal substance use disorder group clinical program specifically created for Native mothers.

Sponsors

University of Utah
Lead SponsorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

We will complete a type I hybrid effectiveness-implementation study to provide important data on clinical effectiveness by comparison to a historical cohort, with a robust statistical analysis plan to address selection bias. We plan to recruit 150 participants prospectively, with an expected final enrollment of 120, and compare them to a deidentified historical cohort of roughly 120 individuals.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

CEREMONY Inclusion Criteria: * English or Spanish speaking * pregnant (verified by point of care urine pregnancy test) * plan to carry the fetus to delivery * identify as Indigenous, Native, Native American, American Indian or Alaska Native * willing to grant a release of information to allow study staff to contact other health care institutions and treatment centers and collect information from the medical record, e.g., date of delivery, infant admission etc. CEREMONY

Exclusion criteria

* have a documented psychotic episode in the last 30 days * be \>39 weeks of gestation * be unable provide collateral contact information of at least 1 person * be unable to provide reliable phone number * plan to move within 3 months of delivery

Design outcomes

Primary

MeasureTime frameDescription
Postpartum engagement in careFrom enrollment until 12 weeks after deliveryCompletion of a postpartum follow up visit within 8 weeks of delivery

Secondary

MeasureTime frameDescription
Medication for opioid use disorderEnrollment through 1 year postpartumAny prescription of suboxone or methadone for individuals with OUD, and the length of time the prescription is kept current

Countries

United States

Contacts

CONTACTValerie Joseph Regulatory Coordinator
valerie.joseph@hsc.utah.edu801-587-2249
CONTACTPriscilla Blosser
priscilla.blosser@hsc.utah.edu801-213-6117
PRINCIPAL_INVESTIGATORMichelle Debbink, MD PhD

University of Utah

PRINCIPAL_INVESTIGATORAdam Gordon, MD

University of Utah

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 8, 2026